Search research articles
Contact Us
Filters
Showing results (881-890 of 889) with videos related to
Page
of 89
Sort By:
You have reached the last page of results.
This site can display upto 889 results.
EFSA Journal. European Food Safety Authority
|
July 7, 2020
Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food
, Helle Katrine Knutsen, Jan Alexander, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
Arxiv
|
July 30, 2025
Monitoring morphometric drift in lifelong learning segmentation of the spinal cord
Enamundram Naga Karthik, Sandrine Bédard, Jan Valošek, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
January 26, 2026
Monitoring morphometric drift in lifelong learning segmentation of the spinal cord
Enamundram Naga Karthik, Sandrine Bédard, Jan Valošek, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)
|
February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)
|
December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Page
of 89
Search research articles
Search
Showing results (881-890 of 889) with videos related to
Sort By:
Page
of 89
You have reached the last page of results.
This site can display upto 889 results.
EFSA Journal. European Food Safety Authority
|
July 7, 2020
Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food
, Helle Katrine Knutsen, Jan Alexander, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 15, 2022
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
Jeremy P Carr, Jenny M MacLennan, Emma Plested, et al.
Microorganisms
|
April 30, 2021
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada, Yangyupei Yang, Julia C Bennett, et al.
Arxiv
|
July 30, 2025
Monitoring morphometric drift in lifelong learning segmentation of the spinal cord
Enamundram Naga Karthik, Sandrine Bédard, Jan Valošek, et al.
Imaging Neuroscience (Cambridge, Mass.)
|
January 26, 2026
Monitoring morphometric drift in lifelong learning segmentation of the spinal cord
Enamundram Naga Karthik, Sandrine Bédard, Jan Valošek, et al.
Lancet (London, England)
|
April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)
|
February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)
|
December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Page
of 89